anti mouse cd8 α (Bio X Cell)
Bio X Cell is a verified supplier 
Bio X Cell manufactures this product 
96
Structured Review
Bio X Cell
anti mouse cd8 α
Anti Mouse Cd8 α, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 204 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+mouse+cd8/InVivoMAb+anti-mouse+CD8%CE%B2/pm42829916-411-4-19
Average 96 stars, based on 204 article reviews
Anti Mouse Cd8 α, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 204 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+mouse+cd8/InVivoMAb+anti-mouse+CD8%CE%B2/pm42829916-411-4-19
Average 96 stars, based on 204 article reviews
anti mouse cd8 α - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
In Vivo:Article Title: Decorin facilitates T cell-mediated antitumor immunity and augments the efficacy of anti-PD1 immunotherapy. Article Snippet: .. In vivo CD8+ T cell depletion: Article Title: Decorin facilitates T cell-mediated antitumor immunity and augments the efficacy of anti-PD1 immunotherapy Article Snippet: .. In vivo CD8 + T cell depletion: Article Title: PARP inhibitors restore NK cell function via secretory crosstalk with tumor cells in prostate cancer Article Snippet: At 18 to 20 days after tumor injection, 150 mg/kg of d -luciferin, potassium salt (Yeasen) was injected into the abdominal cavity of the mice, and in vivo imaging analysis was performed 10 minutes after injection into the body. .. For in vivo depletion of immune cells, 200 μg per mouse of anti-mouse NK-1.1 (Bio X Cell) and Control:Article Title: Decorin facilitates T cell-mediated antitumor immunity and augments the efficacy of anti-PD1 immunotherapy. Article Snippet: .. In vivo CD8+ T cell depletion: Article Title: TROP2/claudin program mediates immune exclusion to impede checkpoint blockade in breast cancer. Article Snippet: .. For CD8+T cell depletion, each mouse was administered intraperitoneally 200 μg Article Title: Decorin facilitates T cell-mediated antitumor immunity and augments the efficacy of anti-PD1 immunotherapy Article Snippet: .. In vivo CD8 + T cell depletion: Article Title: Targeting tumor intrinsic TAK1 engages TNF-α-driven cell death through distinct mechanisms and enhances cancer immunotherapy Article Snippet: Where indicated, mice were treated with anti-mouse PD-1 antibody synthesized at AbbVie (17D2[mu IgG2a/k] DANA) 10 mg/kg, Q4Dx3, IP). .. For the CD8 depletion protocol, mice were injected with Mouse Assay:Article Title: CD28-deficient mice are vulnerable to mouse papillomavirus MmuPV1 infection of the skin and mucosae Article Snippet: .. Mice were injected with either 300 μg of anti-mouse CD4 (clone GK1.5) or 300 μg of Injection:Article Title: CD28-deficient mice are vulnerable to mouse papillomavirus MmuPV1 infection of the skin and mucosae Article Snippet: .. Mice were injected with either 300 μg of anti-mouse CD4 (clone GK1.5) or 300 μg of Article Title: PARP inhibitors restore NK cell function via secretory crosstalk with tumor cells in prostate cancer Article Snippet: At 18 to 20 days after tumor injection, 150 mg/kg of d -luciferin, potassium salt (Yeasen) was injected into the abdominal cavity of the mice, and in vivo imaging analysis was performed 10 minutes after injection into the body. .. For in vivo depletion of immune cells, 200 μg per mouse of anti-mouse NK-1.1 (Bio X Cell) and Article Title: Targeting tumor intrinsic TAK1 engages TNF-α-driven cell death through distinct mechanisms and enhances cancer immunotherapy Article Snippet: Where indicated, mice were treated with anti-mouse PD-1 antibody synthesized at AbbVie (17D2[mu IgG2a/k] DANA) 10 mg/kg, Q4Dx3, IP). .. For the CD8 depletion protocol, mice were injected with other:Article Title: rWTC-MBTA Vaccine, Alone and Enhanced with Anti-PD1, Elicits Immune Responses against CNS and Peripheral B-Cell Lymphoma. Article Snippet: Antibodies, including anti-mouse CD40 (clone FGK4.5), anti-mouse CD4 (clone GK1.5), and Bioprocessing:Article Title: Antibody-mediated conditioning with immunosuppression to enable allogeneic transplantation Article Snippet: .. Each recipient mouse received three consecutive 1 mg injections (days 0, 2 and 4 post-bone marrow infusion) of each of the following monoclonal antibodies: rat anti-mouse CD4 (CD4 cell non-depleting; YTS 177), anti-CD40 ligand (MR1) and |
